- $46.31m
- $21.31m
- $123.10m
Brief: Aikido Reports Formation Of New Financial Services Subsidiary
Brief: Press Release - Significant Investor In Aikido Pharma Urges Board To Commit To Sell Assets
Brief: Aikido Pharma Inc. Appoints New Director, Soo Yu
Brief: Shalom Auerbach - Issues Open Letter To Board Of Directors Of Aikido Pharma
Brief: Aikido Announces Reverse Stock Split
Aikido Pharma Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Aikido Pharma Announces Strategic Investment In Discord, Inc.
NASDAQ RESUMED AT 02:05 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:00 PM
Aikido Pharma Inc expected to post a loss of 1cent a share - Earnings Preview
Brief: Cedars-Sinai Medical Center And Aikido Pharma Inc. Enter Into Master Collaboration Agreement
Aikido Pharma up on plans to collaborate with Cedars-Sinai
Brief: Aikido Pharma Reports Improved Manufacturing Process And New United States Patent For Pancreatic Drug
Brief: Aikido Pharma Announces $22 Million Registered Direct Offering
Brief: Aikido Pharma Announces Share Repurchase Program
Brief: Aikido Pharma Announces Strategic Interest In Asp Isotopes Inc.
Aikido Pharma Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tesla, Dutch Bros, Aspen Technology, pharma stocks
Aikido Pharma rises as Wainwright starts with 'buy'